Bioniq is entering a new chapter.
Today, we announced that Bioniq has entered into an agreement for the sale of its assets to Herbalife, the number one active and lifestyle nutrition brand in the world. This milestone marks an important step forward in our mission to make personalized, data-driven health accessible at a global scale.
Since its founding in 2019, Bioniq has focused on delivering personalized supplement formulas based on blood biomarkers, individual health data, and a proprietary personalization engine. What began as a solution designed for elite athletes has evolved into a global platform serving individuals across a wide spectrum — from everyday wellness consumers to high-performance athletes.
By joining Herbalife’s global infrastructure, Bioniq will be able to scale its science-driven platform across 95 markets, supported by more than 2 million distributors and millions of customers worldwide. This integration will accelerate innovation, expand access, and enhance the delivery of personalized nutrition globally.
“With a professional athletic career behind me, I created Bioniq to make health measurable, actionable, and accessible,” said Vadim Fedotov, Founder of Bioniq. “Our science-driven approach and proven model have positioned us as a leader in personalized nutrition. Joining Herbalife allows us to accelerate our mission and bring personalized health solutions to a global audience at scale.”
The partnership combines Bioniq’s technology and personalization capabilities with Herbalife’s global reach, creating new opportunities to expand access to data-driven health solutions worldwide.
“The future of health and wellness is increasingly personalized and data-driven,” said Stephan Gratziani, Chief Executive Officer of Herbalife. “By combining Bioniq’s technology with our global infrastructure and Pro2col platform, we are uniquely positioned to deliver personalized nutrition to millions of consumers worldwide.”
The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. The $55 million purchase price will be paid over five years, including an initial payment of $10 million at closing. In addition, the transaction value includes up to $95 million of contingent payments based on future performance.
Following closing, Bioniq’s personalized supplements are expected to be introduced through Herbalife’s distributor network in select markets across Europe and the United States, with additional regions to follow.
“Throughout my career, biometrics and personalized nutrition have been central to helping me perform and compete at the highest level. As a longtime Herbalife and Bioniq user, I’ve experienced firsthand how a tailored approach to nutrition can help optimize performance,” said Cristiano Ronaldo. “I’m delighted to see Bioniq’s personalized supplements become part of Herbalife’s expanding access to nutritional supplements, helping people take a more informed approach to their health, wellness and performance.”
This marks an important step forward in making personalized nutrition more widely accessible — while continuing to build the future of precision health.
Read the full press release here: https://ir.herbalife.com/news-events/press-releases/detail/938/herbalife-to-expand-its-personalized-nutritional-supplement
